Skip to Main Content

Author Details

Zhaohui Ye
Center for Biologics Evaluation and Research
2002
71
38
Prashant Mali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37156062Generation of induced pluripotent stem cell lines from helper and cytotoxic T cells of healthy individuals.Stem Cell Res2023
33467883Convergence of human pluripotent stem cell, organoid, and genome editing technologies.Exp Biol Med (Maywood)2021
33408528Study on Targeting Relationship Between miR-320b and FGD5-AS1 and Its Effect on Biological Function of Osteosarcoma Cells.Cancer Manag Res2020
32101839MiR-140-3p Ameliorates the Progression of Osteoarthritis via Targeting CXCR4.Biol Pharm Bull2020
30471152Transient c-Src Suppression During Endodermal Commitment of Human Induced Pluripotent Stem Cells Results in Abnormal Profibrotic Cholangiocyte-Like Cells.Stem Cells2019
31767844Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing.Nat Commun2019
30803263Human-relevant preclinical in vitro models for studying hepatobiliary development and liver diseases using induced pluripotent stem cells.Exp Biol Med (Maywood)2019
30358741Biliary Atresia Relevant Human Induced Pluripotent Stem Cells Recapitulate Key Disease Features in a Dish.J Pediatr Gastroenterol Nutr2019
29164808A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.Stem Cells Transl Med2018
29034890Derivation of a disease-specific human induced pluripotent stem cell line from a biliary atresia patient.Stem Cell Res2017
28395806Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.Stem Cell Res2017
28441409A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement-mediated toxicity in a human iPSC model.PLoS One2017
26896603Genome editing systems in novel therapies.Discov Med2016
27138846Efficient and Controlled Generation of 2D and 3D Bile Duct Tissue from Human Pluripotent Stem Cell-Derived Spheroids.Stem Cell Rev Rep2016
27256364Gene correction in patient-specific iPSCs for therapy development and disease modeling.Hum Genet2016
27037079Genome Editing in Human Pluripotent Stem Cells.Cold Spring Harb Protoc2016
27037073A Method for Genome Editing in Human Pluripotent Stem Cells.Cold Spring Harb Protoc2016
25504624Covalent modification of a cysteine residue in the XPB subunit of the general transcription factor TFIIH through single epoxide cleavage of the transcription inhibitor triptolide.Angew Chem Int Ed Engl2015
25862562Modified Ham test for atypical hemolytic uremic syndrome.Blood2015
25702619Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.Stem Cells2015
25742692A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach.Stem Cells Transl Med2015
25418680Efficient and allele-specific genome editing of disease loci in human iPSCs.Mol Ther2015
23066813Roles of reactive oxygen species in the fate of stem cells.Antioxid Redox Signal2014
25473036Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.Sci Transl Med2014
24996165Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs.Cell Stem Cell2014
24357517Early frameshift mutation in PIGA identified in a large XLID family without neonatal lethality.Hum Mutat2014
24105986Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells.Stem Cells2014
24002691Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factors.Mol Ther2014
23372166RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.Blood2013
24113066Generation of glycosylphosphatidylinositol anchor protein-deficient blood cells from human induced pluripotent stem cells.Stem Cells Transl Med2013
23813938Response: the role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells.Blood2013
23812546Generation and homing of iPSC-derived hematopoietic cells in vivo.Mol Ther2013
23325555Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells.Hepatology2013
22385660Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression.Cell Stem Cell2012
23080273Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression.Nat Protoc2012
22619021Promise and challenges of human iPSC-based hematologic disease modeling and treatment.Int J Hematol2012
22225458Efficient derivation and genetic modifications of human pluripotent stem cells on engineered human feeder cell lines.Stem Cells Dev2012
22305531The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria.Am J Hum Genet2012
21243013Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures.Cell Res2011
21857158Hematopoietic cells as sources for patient-specific iPSCs and disease modeling.Cell Cycle2011
21628406Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells.Blood2011
21750407Liver engraftment potential of hepatic cells derived from patient-specific induced pluripotent stem cells.Cell Cycle2011
21439256Molecular imaging and stem cell research.Mol Imaging2011
21393480Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.Blood2011
20336524An improved method for generating and identifying human induced pluripotent stem cells.Methods Mol Biol2010
20632856Potential of human induced pluripotent stem cells derived from blood and other postnatal cell types.Regen Med2010
20201064Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes.Stem Cells2010
20432258Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes.Hepatology2010
18563409In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC).Cancer Immunol Immunother2009
19797525Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.Blood2009
  • 1 - 50 of 71

Recommended Authors

Integrare Research Unit UMR_S, Universite Paris-Saclay, University Evry, Inserm
Career Start Year 2010
Number of shared co-authors 1
Massachusetts Institute of Technology
Career Start Year 2008
Number of shared co-authors 5
Gladstone Institute of Cardiovascular Disease
Career Start Year 2006
Number of shared co-authors 0
Tokyo Metropolitan Institute of Medical Science, Japan Gladstone Institutes
Career Start Year 2006
Number of shared co-authors 0
Medical University of Vienna
Career Start Year 2005
Number of shared co-authors 0
Stanford University
Career Start Year 2004
Number of shared co-authors 3
Catalan Institution for Research and Advanced Studies (ICREA)
Career Start Year 2004
Number of shared co-authors 2
BioMarin Pharmaceutical Inc.
Career Start Year 2003
Number of shared co-authors 0
Chinese Academy of Sciences
Career Start Year 2003
Number of shared co-authors 3
University of Washington
Career Start Year 2002
Number of shared co-authors 1
University of Macau
Career Start Year 2002
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 0
Center for Reproductive Science, University of California los angeles
Career Start Year 1999
Number of shared co-authors 2
College of Food Science and Technology, Nanjing Agricultural University
Career Start Year 1999
Number of shared co-authors 2
Faculty of Medicine Siriraj Hospital, Mahidol University
Career Start Year 1998
Number of shared co-authors 0
Institute for Cell Engineering, The Johns Hopkins University School of Medicine
Career Start Year 1996
Number of shared co-authors 11
and Blood Institute, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 2
The Florey Institute for Neuroscience and Mental Health, University of Melbourne
Career Start Year 1994
Number of shared co-authors 0
RIKEN BioResource Research Center
Career Start Year 1992
Number of shared co-authors 1
Institute of Stem Cells and Regenerative Medicine (inStem)
Career Start Year 1990
Number of shared co-authors 8
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Career Start Year 1990
Number of shared co-authors 3
Inc., Salk Institute for Biological Studies
Career Start Year 1989
Number of shared co-authors 2
Ottawa Hospital Research Institute
Career Start Year 1989
Number of shared co-authors 2
Carpenter Group Consulting Inc., USA NxCell Inc., USA Q Therapeutics Inc.
Career Start Year 1988
Number of shared co-authors 1
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Career Start Year 1987
Number of shared co-authors 1
Albert Einstein College of Medicine
Career Start Year 1987
Number of shared co-authors 0
Institute of Regeneration and Repair, The University of Edinburgh
Career Start Year 1984
Number of shared co-authors 0
Leiden University Medical Center
Career Start Year 1981
Number of shared co-authors 2
Advanced Research Institute, Tokyo Medical and Dental University
Career Start Year 1981
Number of shared co-authors 3
Vita-Salute San Raffaele University
Career Start Year 1980
Number of shared co-authors 2

Collaborators

Johns Hopkins University School of Medicine
Co-authored papers 51
Daegu Catholic University Medical Center, Catholic University of Daegu
Co-authored papers 18
Sidney Kimmel Cancer Center, Johns Hopkins University
Co-authored papers 10
The Institute for Cell Engineering, Johns Hopkins University
Co-authored papers 10
University of California San Diego
Co-authored papers 10
Johns Hopkins University School of Medicine, Institute for Cell Engineering
Co-authored papers 9
Heidelberg University
Co-authored papers 8
and Blood Institute, National Institutes of Health
Co-authored papers 7
GC Therapeutics Inc.
Co-authored papers 6
and Blood Institute, National Institutes of Health
Co-authored papers 6
Guangzhou University
Co-authored papers 6
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers 5
The Johns Hopkins University School of Medicine
Co-authored papers 5
Johns Hopkins Hospital
Co-authored papers 3
St. Jude Children's Research Hospital
Co-authored papers 3
Chengdu Yumei Hospital
Co-authored papers 3
The Johns Hopkins University School of Medicine
Co-authored papers 3
Key Laboratory of Longevity and Aging-related Diseases(Guangxi Medical University)
Co-authored papers 3
Center for Stem Cell Biology & Regenerative Medicine and.
Co-authored papers 2
and Blood Institute, National Institutes of Health
Co-authored papers 2
Johns Hopkins University School of Medicine
Co-authored papers 2
Shenzhen Alpha-biotechnology Inc. Shenzhen
Co-authored papers 2
Moores Cancer Center, University of California San Diego
Co-authored papers 2
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 2
Johns Hopkins University School of Medicine
Co-authored papers 2
Beijing Institute for Brain Disorders
Co-authored papers 2
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
Amherst College
Co-authored papers 1
Department of Medicine Cardiovascular Institute and Division of Pulmonary
Co-authored papers 1